一个新的磁悬浮心内左心室辅助系统,用于晚期心力衰竭,这是从一个前性的多中心研究中得出的2年结果
Xianqiang Wang1, Haibo Chen1, Juan Du1
1Department of Cardiovascular Surgery, National Center for Cardiovascular Diseases China: Chinese Academy of Medical Sciences & Peking, Union Medical College Fuwai Hospital, Beijing, China.
概括
这项研究表明,Corheart 6左心室辅助系统对晚期心力衰竭患者有效且安全,在两年内无事件生存率为86%. 这种新型设备提供了有希望的长期循环支持.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 临床试验 临床试验
背景情况:
- 左心室辅助器件 (LVAD) 对晚期心力衰竭至关重要.
- 新型小型化,磁悬浮,连续流动的LVAD正在出现.
- 需要对这些新型系统提供长期数据.
研究的目的:
- 评估一种新的小型化LVAD的2年有效性和安全性.
- 评估晚期心力衰竭患者的长期循环支持.
- 介绍一项在中国进行的前性多中心临床试验的结果.
主要方法:
- 未来的多中心临床试验涉及50名严重左心室功能障碍的成年患者.
- 数据收集包括在基线和24个月的生存率,不良事件和功能状态.
- 主要终点:没有致残性中风或设备更换的2年生存率.
主要成果:
- 78%的患者在2年后仍然使用设备支持.
- 两年无事件存活率为86% (95% CI: 73.3% - 94.2%).
- 没有设备故障或血液溶解;主要不良事件包括驱动线感染 (12%) 和中风 (6%).
结论:
- 科尔哈特6 LVAD显示出有希望的长期有效性和安全性.
- 这个系统为晚期心力衰竭提供有效的循环支持.
- 该研究支持在临床实践中使用这种新型LVAD.
相关概念视频
Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Heart Failure V: Medical Management
209
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Heart Failure II: Pathophysiology
704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K


